Dual-energy X-ray Absorptiometry (DEXA) Market Analysis

Dual-energy X-ray Absorptiometry (DEXA) Market Analysis

To get key market trends

  Download Free Sample

The dual-energy x-ray absorptiometry (DEXA) market by technology is segregated into axial DEXA bone densitometer and peripheral DEXA bone densitometer. The axial DEXA bone densitometer garnered more than USD 305.6 million in revenue size in the year 2022. Ongoing technological advancements to enhance the precision and efficiency of axial DEXA scans, reducing radiation exposure and offer broader applications including whole-body composition assessment and paediatric bone health evaluation. High adoption of Axial DEXA systems in research activities and clinical trials related to osteoporosis and fractures will contribute to segmental demand. Moreover, integration of electronic health records (EHR) and telemedicine platforms into axial DEXA systems streamlines data management, enhances patient care coordination and remote interpretation of scans extending access to underserved areas.

Based on type, the dual-energy x-ray absorptiometry (DEXA) market is classified into standalone and portable. The standalone segment accounted for over 59% market share in the year 2022. The substantial surge in the prevalence of osteoporosis due to an aging population and the growing prevalence of risk factors such as fractures. As the number of patients with osteoporosis increases, the demand for dual-energy x-ray absorptiometry (DEXA) for diagnostic procedures will grow substantially in the forthcoming years. Further, increasing awareness among physicians regarding the benefits and effectiveness of DEXA scans led to greater adoption of the product in healthcare settings. Further, several manufacturers are focusing on patient-centric designs for standalone DEXA systems that offer quieter scanning, open configurations, and improved ergonomics will contribute to enhanced patient comfort and reduced anxiety during the procedure.
 

Based on application, the dual-energy x-ray absorptiometry (DEXA) market is subdivided into osteoporosis, body composition analysis, fracture management, bone densitometry, and others. The osteoporosis segment is anticipated to witness substantial expansion at 8.1% CAGR by 2032. The growing prevalence rate of osteoporosis coupled with an increase in the geriatric population that is highly susceptible to bone-related diseases. For instance, as per the Centers for Disease Control and Prevention, more than 18.8% women aged 50 years are suffering from osteoporosis of lumber spine and femur neck in the U.S.
 

Based on end-use, the dual-energy x-ray absorptiometry (DEXA) market is segregated into hospitals & clinics, diagnostic centers, specialty centers, and others. The hospitals & clinics segment is predicted to witness the highest progression to reach over USD 531 million by 2032 attributed to the growing hospital admissions, aging demographics, and high prevalence rate of osteoporosis. Moreover, growing investment in advanced DEXA systems that offer precise bone density assessments and better patient care among facilities. Further, the rising preference for DEXA systems among developed nations due to the high number of obese people that are actively seeking accurate body composition analysis to manage obesity, malnutrition, and other health conditions.
 

U.S. dual-energy x-ray absorptiometry (DEXA) market accounted for USD 197.6 million in revenue size in 2022. The increasing usage of advanced medical technology in healthcare systems, as well as the expanding burden of chronic diseases are some of the major factors driving the U.S. DEXA industry gains. For instance, the American Cancer Society estimated that more than 3,910 new instances of bone and joint cancer in the U.S. in 2022, out of which 1,750 were female patient and over 2,160 were male patients. Since cancer cells and cancer-specific medications have negative effects on bone cells, cancer is a major cause of bone loss and fractures.